Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Zheng Zhang
CONTACT
Lead
Taizhou Mabtech Pharmaceutical Co.,Ltd
This study is a Phase II/III clinical trial, aimed to evaluate the efficacy and safety of Enlituo® combined with Anyouping® plus platinum and nab-paclitaxel chemotherapy as first-line therapy for advanced, recurrent or metastatic HNSCC. Phase II Part Approximately 60 participants will be enrolled and randomly assigned at a 1:1 ratio to the experimental group. Phase III Part Approximately 302 participants will be enrolled and randomly assigned in a 1:1 double-blind manner to the experimental group.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
